Cargando…
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8(+) T Cells
Effector CD8(+) T cells rely primarily on glucose metabolism to meet their biosynthetic and functional needs. However, nutritional limitations in the tumor microenvironment can cause T-cell hyporesponsiveness. Therefore, T cells must acquire metabolic traits enabling sustained effector function at t...
Autores principales: | Chowdhury, Snehanshu, Kar, Anwesha, Bhowmik, Debaleena, Gautam, Anupam, Basak, Debashree, Sarkar, Ishita, Ghosh, Puspendu, Sarkar, Deborpita, Deka, Alvina, Chakraborty, Paramita, Mukhopadhyay, Asima, Mehrotra, Shikhar, Basak, Soumen, Paul, Sandip, Chatterjee, Shilpak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613107/ https://www.ncbi.nlm.nih.gov/pubmed/35648389 http://dx.doi.org/10.1158/0008-5472.CAN-21-4052 |
Ejemplares similares
-
Intratumoral PD1(+)CD38(+)Tim3(+) CD8(+) T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer
por: Basak, Debashree, et al.
Publicado: (2023) -
CD38: T Cell Immuno-Metabolic Modulator
por: Kar, Anwesha, et al.
Publicado: (2020) -
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019) -
Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016) -
The NF-κB Activating Pathways in Multiple Myeloma
por: Roy, Payel, et al.
Publicado: (2018)